Naris Nilubol
Overview
Explore the profile of Naris Nilubol including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
161
Citations
2407
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ballaro R, Wasylishen A, Pieterman C, Olsen C, Irajizad E, Wu R, et al.
Cancer Lett
. 2025 Feb;
614:217537.
PMID: 39924079
Metastatic duodenopancreatic neuroendocrine tumors (dpNETs) are the primary cause of mortality among patients with Multiple Endocrine Neoplasia Type 1 (MEN1). Emerging evidence implicates the microbiome and microbial-derived secreted factors in...
2.
Seitter S, Rossi A, Hernandez J, Nilubol N, Schrump D
J Thorac Dis
. 2024 Nov;
16(10):7123-7131.
PMID: 39552878
Background: Acute esophageal necrosis (AEN) is a rare clinical condition characterized by diffuse, circumferential, black mucosal discoloration of the distal esophagus. The cause is multifactorial, frequently seen as a sequela...
3.
Haque F, Carrasquillo J, Turkbey E, Mena E, Lindenberg L, Eclarinal P, et al.
EJNMMI Res
. 2024 Nov;
14(1):103.
PMID: 39500789
Background: Somatostatin receptor (SSR) targeting radiotracer Ga-DOTATATE is used for Positron Emission Tomography (PET)/Computed Tomography (CT) imaging to assess patients with Pheochromocytoma and paraganglioma (PPGL), rare types of Neuroendocrine tumor...
4.
Friedman L, Ramamoorthy B, Nilubol N
Best Pract Res Clin Endocrinol Metab
. 2024 Oct;
39(1):101954.
PMID: 39366823
Significant advances have been made in the past few decades in surgical management and outcomes of patients with pheochromocytoma and paraganglioma. Improvements in preoperative hypertensive control with the implementation of...
5.
Vocke C, Ricketts C, Pack S, Raffeld M, Hewitt S, Lebensohn A, et al.
J Med Genet
. 2024 Sep;
61(11):1026-1030.
PMID: 39317422
von Hippel-Lindau (VHL) is an autosomal-dominant hereditary tumour susceptibility disease associated with pathogenic germline variants in the tumour suppressor gene. VHL patients are at increased risk of developing multiple benign...
6.
Casey R, Hendriks E, Deal C, Waguespack S, Wiegering V, Redlich A, et al.
Nat Rev Endocrinol
. 2024 Aug;
20(12):760.
PMID: 39191988
No abstract available.
7.
Casey R, Hendriks E, Deal C, Waguespack S, Wiegering V, Redlich A, et al.
Nat Rev Endocrinol
. 2024 Aug;
20(12):729-748.
PMID: 39147856
Phaeochromocytomas and paragangliomas (PPGL) are rare neuroendocrine tumours that arise not only in adulthood but also in childhood and adolescence. Up to 70-80% of childhood PPGL are hereditary, accounting for...
8.
Jha A, Patel M, Ling A, Shah R, Chen C, Millo C, et al.
Eur Radiol
. 2024 Apr;
34(10):6488-6498.
PMID: 38625612
Objective: To compare the diagnostic performance of [Ga]DOTATATE PET/CT, [F]FDG PET/CT, MRI of the spine, and whole-body CT and MRI for the detection of pheochromocytoma/paraganglioma (PPGL)-related spinal bone metastases. Materials...
9.
Kolli V, Frucci E, da Cunha I, Iben J, Kim S, Mallappa A, et al.
Int J Mol Sci
. 2024 Mar;
25(5).
PMID: 38473790
Adrenal myelolipomas (AML) are composed of mature adipose and hematopoietic components. They represent approximately 3 percent of adrenal tumors and are commonly found in patients with congenital adrenal hyperplasia (CAH)....
10.
Graf A, Cochran C, Sadowski S, Nilubol N, Simonds W, Weinstein L, et al.
J Endocr Soc
. 2024 Jan;
8(1):bvad158.
PMID: 38174154
Context: The identification of parathyroid tumor(s) in patients with persistent/recurrent primary hyperparathyroidism (PHPT) is critical for a successful reoperative surgery. If noninvasive studies (ultrasound, computed tomography, magnetic resonance imaging, sestamibi)...